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Abstract:  One  new  ʱ-pyrone  (nocapyrone  R  (1)),  and  three  known  γ-pyrones  
(nocapyrones B, H and L (2–4)) were isolated from the culture extract of a Nocardiopsis 
strain collected from marine sediment. Structures of these compounds were determined on the 
basis of spectroscopic data including NMR and MS. γ-Pyrones 2–4 were found to induce 
adiponectin production in murine ST-13 preadipocyte cells but the ʱ-pyrone 1 had no activity. 
The absolute configuration of the anteiso-methyl branching in 4 was determined by HPLC 
comparison of a degraded product of 4 with standard samples as a 2:3 enantiomeric mixture 
of (R)- and (S)-isomers. 
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1. Introduction 
Natural products have been playing an important role for the development of novel therapeutics 
owing to their enormous and unpredictable structural diversity [1]. Specifically, actinomycetes are 
continuously providing structurally diverse secondary metabolites possessing pharmaceutically useful 
bioactivities. More than 70% of microbial antibiotics have been discovered from actinomycetes [2].  
In recent years, in addition to the terrestrial species, actinomycetes from marine environments are 
attracting  a  substantial  attention  as  a  new  resource  of  novel  drug  candidates  [3].  The  differences 
between  the  marine  and  terrestrial  environments  are  likely  reflected  in  the  genetic  divergences. 
Marine-derived actinomycetes are recognized to actually produce a range of chemically distinctive 
secondary metabolites that terrestrial actinomycetes are not able to produce [4]. Consequently, the 
number of novel metabolites from marine actinomycetes has been increasing in recent years. 
The increasing incidents of type 2 insulin-resistant diabetes, as a result of growing obesity rates, are 
causing  a  serious  social  and  economic  problem  [5].  Adipose  tissue  secretes  various  types  of 
biologically active adipokines, such as free fatty acids, tumor necrosis factor-ʱ, adiposin, resistin, and 
leptin, to regulate energy homeostasis [6]. Adiponectin is one of such adipokines secreted exclusively 
by mature adipocytes [7] and this proteineous substance functions to regulate the glucose and lipid 
metabolism [8]. Recent research revealed that the mRNA expression of adiponectin is reduced in obese 
diabetic murine model [9] and type 2 diabetic patients [10–12], and also plasma level of adiponcetin is 
significantly  lower  in  obese  diabetic  mice  and  humans  [13–15].  Therefore,  the  replenishment  of 
adiponectin  by  transcriptional  induction  in  adipocytes  is  believed  to  provide  a  new  effective 
therapeutic approach to insulin resistance, type 2 diabetes, and related diseases. Thiazolidinediones 
represented by rosiglitazone (Avandia) and pioglitazone (Actos) are widely-used orally available drugs 
for type 2 diabetes. These synthetic compounds activate transcription by PPARγ (peroxisome proliferator 
activated receptor γ) primarily in adipose tissues and induce the elevation of adiponectin plasma level. 
Meanwhile,  several  research  groups  have  demonstrated  that  serious  side  effects  are  caused  by 
rosiglitazone; the use of this drug is associated with a 43% increase in myocardial infraction and 64% 
increase in the risk of death from cardiovascular causes [16]. Thus, the development of side effect-free 
new agents for type 2 diabetes is desperately desired. In our screening program for discovering new 
lead scaffolds for adiponectin inducers from natural products [17–19], a marine-derived Nocardiopsis 
strain was found to produce a new ʱ-pyrone (1) along with three known γ-pyrones, nocapyrones B, H, 
and L (2–4, Figure 1). Interestingly, nocapyrone L (4) was isolated as an enantiomeric mixture, which 
is noticeable in marine natural products. Herein, we describe isolation, structure determination, and 
biological activities of these compounds. 
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Figure 1. Structures of nocapyrones R (1), B (2), H (3), and L (4). 
 
2. Results and Discussion 
2.1. Structure Analysis and Characterization 
2.1.1. Isolation 
The  producing  strain  TP-A0876  was  isolated  from  a  sediment  sample  collected  at  −775  m  in 
Ishikari gulf, Hokkaido, Japan. On the basis of the result of 16S rRNA gene sequence similarity,  
the isolate was identified as Nocardiopsis sp. The strain TP-A0876 was cultured in A-3M medium  
at 30 ° C for 6 days and the whole culture broth was extracted with 1-butanol. The crude extract was 
subjected to silica gel and ODS column chromatographies, followed by HPLC purification, to yield 
nocapyrone R (1) along with nocapyrones B, H, and L (2–4), three known compounds previously 
isolated from marine Nocardiopsis strains by other groups [20,21]. 
2.1.2. Nocapyrone R (1) 
Nocapyrone R (1) was isolated as colorless amorphous. The molecular formula of 1 was determined 
as  C15H24O3  by  high  resolution  ESITOFMS  (Electrospray  Ionization  Time  Of  Flight  Mass 
Spectrometry) analysis that showed a pseudomolecular ion at m/z 275.1619 [M + Na]
+ (calcd for 
C15H24O3Na,  275.1623),  which  was  corroborated  by  the 
1H  and 
13C  NMR  data.  The  IR  spectrum 
indicated the presence of alkene (2944 cm
−1) and carbonyl (1660 cm
−1) groups. 
1H and 
13C NMR data in 
combination  with  the  HSQC  (Heteronuclear  Single  Quantum  Coherence)  analysis  revealed  the 
presence  of  15  carbons  assignable  to  one  carbonyl  carbon,  four  sp
2  quaternary  carbons,  four  sp
3 
methylenes, one sp
3 methine, and five methyl groups (one is oxygenated) (Table 1, Supplementary 
Figures S1, S2 and S4). The NMR spectra of nocapyrone R (1) showed the resonances for a pyrone 
unit  as  well  as  two  methyl  (C-13  and  C-15)  and  one  methoxy  (C-14)  substituents  (Table  1, 
Supplementary Figures S1 and S2): however, the UV spectrum showing absorption maximum at λmax  
290 nm was different from that for γ-pyrone (2–4: UV λmax 252 nm). Furthermore, the ester carbonyl 
absorption of IR spectrum and the ester carbonyl signal of 
13C NMR suggested the presence of an 
ester/lactone  functionality.  Protons  of  two  olefinic  methyl  groups  (H3-13  and  H3-15)  had  HMBC 
correlations with C-3, to which was correlated the methoxy protons (H3-14), establishing the ʱ-pyrone 
substructure with a methoxy group at C-3 flanked by two olefinic methyl groups (Supplementary 
Figure  S5).  The 
1H-
1H  COSY spectrum provided  two fragments, H2-6/H2-7/H2-8/H2-9 and  H3-11/ 
H-10/H3-12. These two fragments were assembled into an alkyl chain bearing an isopropyl terminus by 
HMBC correlations from H3-12 to C-9, C-10, and C-11. This was consistent with the presence of two Mar. Drugs 2014, 12  4113 
 
 
doublet methyl proton signals for H3-11 and H3-12 (Supplementary Figures S3 and S5). The alkyl side 
chain was attached to C-5 by HMBC correlations from H2-6 to C-4 and C-5, completing the structure 
of 1 (Figure 2). 
Table 1. 
1H and 
13C NMR data for nocapyrone R (1) in CDCl3. 
Position  ʴC 
a  ʴH mult (J in Hz) 
b  COSY 
b  HMBC 
b,c 
1  166.3, qC       
2  109.3, qC       
3  168.4, qC       
4  109.0, qC       
5  159.3, qC       
6  31.1, CH2  2.49, t (7.8)  7  4, 5, 7 
7  27.7, CH2  1.61, m  6, 8  5 
8  27.1, CH2  1.31, m  7, 9  10 
9  38.7, CH2  1.18, m  8  7, 11, 12 
10  27.9, CH  1.52, m    11, 12 
11  22.6, CH3  0.86, d (6.5)  10, 12  9, 10, 12 
12  22.6, CH3  0.86, d (6.5)  10, 11  9, 10, 11 
13  10.2, CH3  2.03, s    1, 2, 3 
14  60.2, CH3  3.80, s    3 
15  10.1, CH3  1.92, s    3, 4, 5 
a  recorded  at 100  MHz; 
b recorded  at 500  MHz; 
c  HMBC  correlations  are from  proton(s)  stated to  the 
indicated carbon. 
Figure 2. 2D-NMR correlations for nocapyrone R (1). 
 
2.1.3. Absolute Configuration of Nocapyrone L (4) 
Nocapyrone L (4) has been reported as a secondary metabolite of Nocadiopsis sp. isolated from a 
mollusk as a symbiotic bacterium [21]. Due to the remoteness of the branched methyl chiral center  
(C-10) from the modifiable functional groups, the absolute configuration of 4 had not been assigned. 
From the structural analogy of 4 to germicidin A, we hypothesized that 4 could be biosynthesized 
through condensation of an amino acid-derived starter with malonate extenders [22]. Consequently, the 
anteiso-subunit  known  to  be  originated  from  L-isoleucine  is  assumed  to  have  S  configuration. 
Interestingly, the specific rotation of 4 we isolated showed [ʱ]D
25 = −2.2 (c = 0.1, CHCl3), while that of 
reported one is [ʱ]D
25 = +9.0 (c = 0.1, CHCl3) [21]. In order to clarify the absolute configuration of 4, 
Ohrui-Akasaka method was applied (Scheme 1) [23]. The pyrone unit of 4 was oxidatively degraded Mar. Drugs 2014, 12  4114 
 
 
by the treatment with a catalytic amount of ruthenium (III) chloride and sodium periodate in a biphasic 
solvent  system  (CCl4–MeCN–H2O)  to  give  6-methyloctanoic  acid  5  [24].  This  anteiso-fatty  acid  
was  then  esterified  with a  chiral anthracene reagent,  (R)-2-(anthracene-2,3-dicarboximido)propanol 
[(R)-2A1P], to yield nat-5-(R)-2A1P (Supplementary Figure S6). HPLC analysis of this derivative was 
performed on Develosil ODS-HG-3 column (4.6 mm ×  150 mm, column temp. −58.5 ° C) with the 
eluent of MeOH/MeCN/THF (4:3:1) at a flow rate of 0.2 mL/min. (S)-6-Methyloctanoic acid [(S)-5], 
which was prepared from commercially available (S)-6-methyloctanol, was labeled with (R)-2A1P or 
(S)-2A1P to give reference samples, (S)-5-(R)-2A1P and (S)-5-(S)-2A1P (Supplementary Figures S7 
and S8). Retention times of reference samples were 130.5 min for (S)-5-(S)-2A1P (corresponding to 
(R)-5-(R)-2A1P diastereomer) and 139.3 min for (S)-5-(R)-2A1P (Figure 3a). Surprisingly, nat-5-(R)-2A1P 
derived from 4 showed two peaks for (R)-5-(R)-2A1P and (S)-5-(R)-2A1P in a ratio of 2:3 (Figure 3b). 
Consequently, nocapyrone L (4) was confirmed as an enantiomeric mixture of (R)- and (S)-isomers in 
a ratio of 2:3. This was supported by the 
1H NMR signal for C-6 methyl protons of nat-5-(R)-2A1P, 
which showed overlapped signals for those of (S)-5-(S)-2A1P and (S)-5-(R)-2A1P (Figure 4). 
Scheme 1. Degradation of 4 to 5 and labeling with (R)-2A1P. 
 
Figure  3.  Determination  of  absolute  configuration  of  anteiso-methyl  group  by  HPLC.  
(a)  HPLC  chromatogram  of  standard  (S)-5-(S)-2A1P  (right  graph)  and  (S)-5-(R)-2A1P  
(left graph); (b) HPLC chromatogram of nat-5-(R)-2A1P. 
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Figure  4.  Expanded 
1H  NMR  spectra  of  nat-5-(R)-2A1P,  standard  (S)-5-(S)-2A1P  and  
(S)-5-(R)-2A1P. (a) comparison of nat-5-(R)-2A1P (bottom) with standard (S)-5-(S)-2A1P 
(top) and (S)-5-(R)-2A1P (middle); (b) analysis of 
1H NMR signal of nat-5-(R)-2A1P. 
 
2.2. Biological Activities 
Activity of compounds 1–4 to promote adiponectin-production in adipocyte cells was assessed by 
measuring the mRNA expression level of adiponectin-coding gene [25]. After the treatment of murine 
ST-13  preadipocyte  cells  with  the  compounds  for  11  days,  the  total  mRNA  was  subjected  to 
quantitative real-time PCR analysis. All the γ-pyrones (2–4) enhanced the expression of adiponectin 
mRNA in a concentration-dependent manner while the ʱ-pyrone (1) showed no such effect (Figure 5). 
Especially, 2 and 4 more strongly induced adiponectin production at 8 μM and at the same concentration 
the accumulation of lipid droplets were  observed  (Figure  6, oil red O staining) that  indicates  the 
differentiation to mature adipocyte cells. Compound 2 was further examined for the transcriptional 
activation  of  PPARγ  that  is  the  main  target  of  the  antidiabetic  drug,  thiazolidinediones.  In  the  
luciferase  reporter  assay,  troglitazone  activated  the  transcription  through  PPARγ  but  2  did  not  
(Figure 7), confirming  that  2 is  not  a ligand for  PPARγ  and  its mode  of action is different from 
thiazolidinediones.  These  effects  on  adipocytes  or  adiponectin-inducing  activity  have  not  been 
described for nocapyrones and other related pyrone compounds. 
Figure 5. Effect of nocapyrones on expression of adiponectin mRNA (ROS = rosiglitazone, 20 nM). 
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Figure 6. Adipocyte differentiation induced by nocapyrones B and L. 
 
Figure 7. Effect of nocapyrone B on activation of PPARγ in luciferase ligand assay system. 
 
3. Experimental Section 
3.1. General Experimental Procedures 
Optical  rotation  was  measured  using  a  JASCO  DIP-3000  polarimeter  (JASCO  Corporation, 
Hachioji,  Japan).  UV  spectra  were  recorded  on  a  Hitachi  U-3210  spectrophotometer  (Hitachi  
High-Technologies  Corporation,  Tokyo,  Japan).  IR  spectra  were  measured  on  a  Perkin-Elmer 
Spectrum 100 (Perkin-Elmer Japan Co. Ltd., Yokohama, Japan). NMR spectra were obtained on a 
Bruker  AVANCE  400  (Bruker  BioSpin  K.K.,  Yokohama,  Japan)  or  a  Bruker  AVANCE  500 
spectrometer (Bruker BioSpin K.K., Yokohama, Japan). HR-ESI-TOFMS were recorded on a Bruker 
microTOF focus (Bruker Daltonics K.K., Yokohama, Japan). Cosmosil 75C18-PREP (Nakalai Tesque, 
Inc., Kyoto, Japan, 75 μm) was used for ODS column chromatography. 
3.2. Microorganism 
Strain TP-A0876 was isolated from a sediment sample collected at a depth of 775 m off the island 
of Hokkaido (N 42° 56′80″, E 140° 06′32″), Japan in 2006 (August), using a piston corer. The strain 
was identified as a member of the genus Nocardiopsis on the basis of 100% 16S rRNA gene sequence Mar. Drugs 2014, 12  4117 
 
 
(1455  nucleotides;  GenBank  accession  number  AB488799)  similarity  to  Nocardiopsis  sp.  123 
(accession number AY036002). 
3.3. Fermentation 
Strain TP-A0876 cultured on a Bn-2 agar plate soluble starch 0.5%, glucose 0.5%, meat extract 
(Kyokuto Pharmaceutical Industrial Co., Ltd., Tokyo, Japan) 0.1%, yeast extract (Difco Laboratories, 
Surrey, United Kingdom) 0.1%, NZ-case (Wako Pure Chemical Industries, Ltd., Osaka, Japan) 0.2%, 
NaCl 0.2%, CaCO3 0.1% and agar 1.5%] was inoculated into 500-mL K-1 flasks each containing 100 mL 
of the V-22 seed medium consisting of soluble starch 1%, glucose 0.5%, NZ-case 0.3%, yeast extract 
0.2%, Tryptone (Difco Laboratories) 0.5%, K2HPO4 0.1%, MgSO4· 7H2O 0.05%, and CaCO3 0.3% 
(pH 7.0). The flasks were placed on a rotary shaker (200 rpm) at 30 ° C for 4 days. The seed culture  
(3 mL) was transferred into 500-mL K-1 flasks each containing 100 mL of the A-3M production 
medium consisting of glucose 0.5%, soluble starch 2.0%, glycerol 2.0%, yeast extract 0.3%, Pharmamedia 
(Trader’s  Protein)  1.5%,  and  Diaion  HP-20  (Mitsubishi  Chemical  Holdings  Corporation,  Tokyo, 
Japan) 1%. The pH of the medium was adjusted to 7.0 before sterilization. The inoculated flasks were 
placed on a rotary shaker (200 rpm) at 30 ° C for 7 days. 
3.4. Extraction and Isolation 
At the end of the fermentation period, 100 mL of 1-butanol was added to each flask, and they were 
allowed to shake for one hour. The mixture was centrifuged at 5000 rpm for 10 min and the organic 
layer  was  separated  from  the  aqueous  layer  containing  the  mycelium.  Evaporation  of  the  solvent  
gave 7.8 g of extract from 2 L of culture. The crude extract (7.8 g) was subjected to silica gel column 
chromatography with a step gradient of CHCl3/MeOH (1:0, 20:1, 10:1, 4:1, 2:1, 1:1, and 0:1 v/v). 
Fractions 2 (20:1) and 3 (10:1) were combined and concentrated in vacuo to give brown oil (0.97 g) 
which  was  further  fractionated  by reverse-phase  ODS  column  chromatography  with  a  gradient  of 
MeCN/distilled water (2:8, 3:7, 4:6, 5:5, 6:4, 7:3, and 8:2 v/v). Fractions 4 (5:5) and 5 (6:4) were 
combined and evaporated and the remaining aqueous solution was extracted with EtOAc. The organic 
layer was washed with brine, dried over anhydrous Na2SO4, filtered, and evaporated to dryness. The 
residual  brown  solid  (0.28  g)  was  then  subjected  to  HPLC  purification  using  an  ODS  column 
(Cosmosil  ARII,  10  mm  ×  250  mm)  with  55%  MeCN  in  distilled  water  at  3.0  mL/min  to  give 
nocapyrone B (2, tR 28.1 min, 10 mg), nocapyrone H (3, tR 31.3 min, 2.3 mg) and a mixture of 
nocapyrones  R  and  L  (1  and  4,  tR  41.2  min,  3.8  mg).  1  and  4  were  separated  by  using  a  
cholesterol-bonded reverse-phase column (Cosmosil Cholester, 10 mm ×  250 mm) with 55% MeCN in 
distilled water at 3.0 mL/min to give 4 (tR 29.9 min, 2.1 mg) and 1 (tR 35.0 min, 0.8 mg). 
Nocapyrone R (1): colorless amorphous solid; UV (MeOH) λmax (log ε) 290 (4.04) nm; IR (ATR) 
νmax 2944, 1660 cm
−1; 
1H and 
13C-NMR data, see Table 1; HRESITOFMS m/z 275.1619 [M + Na]
+ 
(calcd for C15H24O3Na, 275.1623).  
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3.5. Determination of the Absolute Configuration of the Anteiso-Methyl Group in 4 by  
Ohrui-Akasaka Method 
Oxidative Degradation of 4 to Yield 5: A solution of nocapyrone L (4, 4 mg, 15 μmol) in a mixture 
of MeCN (320 μL) and H2O (240 μL) was stirred with NaIO4 (19.2 mg, 89 μmol) until the salt was 
dissolved. To this solution were added CCl4 (320 μL) and 1 mg/mL solution of RuCl3 hydrate in 0.1 M 
sodium phosphate buffer (240 μL, pH 7.6) and the biphasic mixture was vigorously stirred at room 
temperature for 17 h. The reaction mixture was passed through Celite and the filter cake was washed 
with  MeCN.  After  evaporation  of  the  organic  solvent  from  the  filtrate,  the  aqueous  solution  was 
acidified  with  2  M  HCl  and  extracted  with  EtOAc.  The  EtOAc  layer  was  concentrated  and  the 
remaining material was dissolved in MeOH (1 mL) and THF (1 mL). To this solution was added 1 M 
NaOH (1 mL) and the mixture was stirred at room temperature for 12 h. The reaction mixture was then 
acidified with 2 M HCl and extracted with EtOAc. The EtOAc layer was washed with water and brine, 
dried over anhydrous Na2SO4, and concentrated in vacuo to give 6-methyloctanoic acid (5, 1.2 mg) 
which was used for the next reaction without further purification:
1H NMR (CDCl3, 500 MHz) δ 0.84 
(3H, d, J = 6.0 Hz), 0.85 (3H, t, J = 7.6 Hz), 1.12 (2H, m), 1.28–1.35 (5H, m), 1.62 (2H, m), 2.36  
(1H, t, J = 7.5 Hz). 
Preparation of nat-5-(R)-2A1P: 6-Methyloctanoic acid (5) obtained by degradation of nocapyrone L 
(4) was reacted with (R)-2-(anthracene-2,3-dicarboximido)propanol [(R)-2A1P] (2 mg, 6.6 μmol) in 
dry CH2Cl2 (1 mL) in the presence of EDAC (2 mg, 10 μmol) and DMAP (trace amount) at room 
temperature for 17 h. The reaction mixture was diluted with ice-water and extracted with EtOAc. The 
organic layer was concentrated under reduced pressure and the residue was chromatographed over a 
silica gel column (n-hexane–EtOAc = 1:0~1:1) to give (R)-2A1P ester derivative of naturally occurring 
6-methyloctanoic acid [nat-5-(R)-2A1P, 0.8 mg]. 
Preparation  of  standard  (S)-6-methyloctanoic  acid:  To  a  solution  of  (S)-6-methyl-1-octanol  
(10 mg, 69 μmol, Wako Pure Chemical Industries, Ltd., Osaka, Japan) in acetone (1 mL) was added 
Jones reagent (0.4 mL, 80 μmol) dropwise. After stirring for 3 h at room temperature, the reaction 
mixture  was  extracted  with  EtOAc  and  the  organic  layer  was  concentrated  in  vacuo  to  give  
(S)-6-methyloctanoic acid (7.0 mg): 
1H NMR (CDCl3, 500 MHz) δ 0.85 (3H, t, J = 5.5 Hz), 0.87 (3H, d, 
J = 7.0 Hz), 1.25–1.35 (5H, m), 1.33 (2H, m), 1.62 (2H, m), 2.36 (3H, t, J = 7.5 Hz). 
Preparation of standard (S)-5-(R)-2A1P and (S)-5-(S)-2A1P: In the same manner as described for 
the preparation of nat-5-(R)-2A1P, (S)-5-(R)-2A1P and (S)-5-(S)-2A1P were prepared by the reaction 
of (S)-6-methyloctanoic acid with (R)- and (S)-2A1P, respectively. 
(S)-5-(R)-2A1P: 
1H NMR (CDCl3, 500 MHz) δ 0.72 (3H, d, J = 5.2 Hz), 0.74 (3H, t, J = 6.7 Hz), 
0.97 (2H, m), 1.11–1.25 (5H, m), 1.49 (2H, m), 1.57 (2H, d, J = 7.1 Hz), 2.22 (2H, t, J = 7.7 Hz), 4.61 
(1H, t, J = 6.1 Hz), 4.43 and 4.73 (2H, m), 7.62 (1H, dd, J = 6.5, 2.9 Hz), 8.07 (1H, dd, J = 6.3,  
2.8 Hz), 8.48 (1H, s), 8.60 (1H, s). 
(S)-5-(S)-2A1P: 
1H NMR (CDCl3, 500 MHz) δ 0.71 (3H, d, J = 5.9 Hz), 0.74 (3H, t, J = 6.8 Hz), 
0.96 (2H, m), 1.13–1.25 (5H, m), 1.48 (2H, m), 1.57 (2H, d, J = 7.1 Hz), 2.23 (2H, t, J = 7.7 Hz), 4.62 
(1H, t, J = 6.1 Hz), 4.44 and 4.74 (2H, m), 7.62 (1H, dd, J = 7.0, 3.1 Hz), 8.07 (1H, dd, J = 6.3,  
2.8 Hz), 8.48 (1H, s), 8.60 (1H, s). Mar. Drugs 2014, 12  4119 
 
 
HPLC analysis: nat-5-(R)-2A1P derived from nocapyrone L (4) and synthetic (S)-5-(R)-2A1P and 
(S)-5-(S)-2A1P  were  analyzed  by  HPLC  under  the  following  conditions.  Column:  Develosil  
ODS-HG-3 (4.6 mm ×  150 mm, Nomura Chemical); mobile phase: MeOH/MeCN/THF=4:3:1; column 
temperature: −58.5 ° C; flow rate: 0.2 mL/min. The column was cooled by using Cryocool CC-100 
(Neslab  Instruments  Inc.,  Portsmouth,  NH,  USA).  HPLC  peaks  were  detected  by  monitoring 
fluorescence intensity at 460 nm with the excitation at 362 nm by using an FP-920 fluorescence detector 
(JASCO  Corporation,  Hachioji,  Japan).  Retention  times  were  130.5  min  for  (S)-5-(S)-2A1P  and  
139.3 min for (S)-5-(R)-2A1P. Natural product-derived nat-5-(R)-2A1P gave peaks at 130.8 min and 
139.3 min in a ratio of 2:3. 
3.6. Biological Activity Study 
Adipocyte differentiation assay was carried out according to the procedure previously described [25]. 
3.6.1. Real-Time Quantitative PCR Analysis 
The total RNA (1 μg) was reverse-transcribed to cDNA using a Super Script TM II RT (Invitrogen, 
Tokyo, Japan). To quantitatively estimate the mRNA levels of several genes, PCR amplification was 
performed using a Light Cycler system (Roche Diagnostic Co., Tokyo, Japan). Real-time PCR was 
carried out in a total volume of 20 μL containing 500 nM each of gene-specific primers, cDNA, and 
SYBRP remix Ex Tag (Takara, Kyoto, Japan). Expression was normalized to glyceraldehyde-3-phosphate 
dehydrogenase  (GAPDH).  Thermal  cycling  conditions  for  the  PCR  were  95  °C   for  5  min,  
followed by 45 cycles of 95 ° C for 5 s, 60 °C  for 15 s, and 72 °C  for 10 s, then a melting curve  
analysis  from  65  °C   to  95  °C ,  every  0.1  °C .  The  primer  sequences  used  were:  adiponectin,  
5′-GAAGCCGCTTATATGTATCG-3′ (forward) and 5′-GCCGTCATAATGATTCTGT-3′ (reverse); 
GAPDH,  5′-CCAGAACATCATCCCTGC-3′  (forward)  and  5′-CCACGACGGACACATT-3′ 
(reverse);  fatty  acid-binding  protein  (aP2),  5′-GAAATCACCGCAGACG-3′  (forward)  and  
5′-ACATTCCACCACCAGC-3′  (reverse);  PPARγ2,  5′-CTGTTGACCCAGAGCA-3′  (forward)  and 
5′-GCGAGTGGTCTTCCAT-3′ (reverse). 
3.6.2. Oil Red O Staining 
ST-13  cells  treated  with  nocapyrones  B  and  L  for  11  days  were  washed  three  times  with  
phosphate-buffered  saline  (PBS),  fixed  with  10%  formalin  neutral  buffer  solution  (Wako  Pure 
Chemical, Osaka, Japan) at room temperature for 10 min, and then washed with distilled water to 
remove formalin solution. Furthermore, the cells were rinsed with 60% 2-propanol for 5 min, stained 
with 0.24% oil red O at room temperature for 20 min, and then were photographed under a phase 
contrast microscope (× 100 magnification) equipped with a CCD camera (Leica Microsystems Japan, 
Tokyo, Japan). 
3.6.3. Luciferase Reporter Assay 
An expression plasmid containing the ligand binding domain of human PPARγ fused to the GAL4 
DNA  binding  domain  (pPPARγ-GAL4),  and  the  luciferase  reporter  plasmid,  17m2G  TATA  Luc Mar. Drugs 2014, 12  4120 
 
 
(p17m2G), were kindly donated by Dr. S. Kato (University of Tokyo, Tokyo, Japan). We transiently 
transfected COS-1 cells (6 ×  10
5 cells) with pPPARγ-GAL4 (0.25 μg) and p17m2G (1 μg) using 
Effectene Transfection Reagent (QIAGEN, Tokyo, Japan). Transfections were performed in triplicate 
in  24-well  plates  according  to  the  manufacture’s  instructions.  After  16  h,  the  transfected  cells  
received  the  indicated  concentrations  of  nocapyrones  B  (or  troglitazone),  and  were  cultured  for 
additional 24 h at 37 ° C in a 5% CO2 incubator. Then cells were harvested and luciferase activities 
were measured by a Steady-Glo
® Luciferase Assay System (Promega, Madison, WI, USA) according to 
manufacturer’s instructions. 
4. Conclusions 
In  this  study,  a  marine-derived  actinomycete  Nocardiopsis  sp.  TP-A0876  was  isolated  from  a 
sediment  sample  and  its  secondary  metabolites  were  investigated.  Purification  from  the  1-butanol 
extract of the culture broth resulted in isolation of one ʱ-pyrone and three γ-pyrones. Based on the 
spectroscopic analysis, the ʱ-pyrone was confirmed as a new compound, whereas other three γ-pyrones 
were identified as nocapyrones B (2), H (3), and L (4). Biological testing in a set of assays proved that  
γ-pyrone  compounds  (2–4)  have  ability  to  induce  preadipocyte  differentiation  and  adiponectin 
production in murine ST13 preadipocyte cells. Since the ʱ-pyrone compound 1 showed no activity, the 
γ-pyrone structure is proposed to play a key role in this activity. 
A large number of pyrone–containing marine natural products are known [26–32]. Specifically, a 
series  of  nocapyrones  (A–Q)  have  been  continuously  reported  from  marine-derived  Nocardiopsis 
strains with a wide range of bioactivity (Figure 8). Nocapyrones B (2) and H (3) modulate nerve cell 
depolarization,  activate  or  inhibit  Ca
2+  flux  into  a  panel  of  human  cells  overexpressing  various 
transient receptor potential (TRP) channels depending upon the agent and channel subtype, together 
with  cytotoxicity  against  human  breast  adenocarcinoma,  but  have  no  antibacterial  activity  [21]. 
Nocapyrones E–G are described to have modest antibacterial activity against Bacillus subtilis [30]. 
Nocapyrone H* inhibits NO production in LPS-stimulated BV-2 microglial cells and neuro-protective 
effect [31], and nocapyrones H*, I*, and M* were shown to suppress gene expression in quorum 
sensing  [32].  However,  there  is  no  report  on  the  activity  of  these  pyrones  for  preadipocyte 
differentiation or adiponectin production. Although the effectiveness is lower than thiazolidinediones, 
different mode of action of the γ-pyrones may provide an opportunity of drug development from this 
new therapeutic scaffold for insulin resistance type 2 diabetes. The concise synthetic strategies [33–36] 
and interesting bioactivities of structurally related compounds have been reported [37,38]. On the base 
of these studies, further synthetic and biological studies of nocapyrone families could be inspiring.  
The absolute configuration of anteiso-methyl group is known and believed to be S in most cases 
because it is derived from L-isoleucine. However, the anteiso-methyl branching in 4 was confirmed as 
a mixture of (R)- and (S)-configurations in a ratio of 2:3. Along with the advances in synthetic and 
analytical  techniques,  several  enantiomeric  mixtures  have  been  discovered  in  natural  products  
(Figure 9) [39–41]. Many of them are marine-derived: trichodenone A, an antitumor metabolite of 
Trichoderma  harzianum  isolated  from  marine  sponge  (Halichondria  okadai),  is  an  (R)-  and  
(S)-enantiomeric mixture [39]; pericosines B and C, metabolites of Periconia byssoide isolated from 
sea hare Aplysia kurodai, bearing four chiral centers are also enantiomeric mixtures [40]. Recently, the Mar. Drugs 2014, 12  4121 
 
 
enantiomeric mixture regarding to the anteiso-methyl asymmetry was found in the insect pheromone.  
4,8-Dimethyldecanal, the male aggregation pheromone of the red flour beetle (Tribolium castaneum), 
consists of four diastereomers, (4R, 8R)-, (4R, 8S)-, (4S, 8R)-, and (4S, 8S)-forms in a ratio of 4:4:1:1 [41]. 
To the best of our knowledge, nocapyrone L (4) is the first microbial metabolite proved to comprise an 
enantiomeric pair of R- and S-configurations at the anteiso-methyl substituent. The sec-methyl group 
at C-10 of nocapyrones C [20] and M [21] are reported to be an R/S-mixture but these compounds have 
a hydroxyl group on the neighboring carbon [21]. Biosynthetic origin of their anteiso-methyl portion 
should be clarified. Further investigation, focused on the biosynthetic precursors and gene analysis 
with our nocapyrone H (4), are under way to identify the enzymatic reactions responsible for the 
formation of enantiomeric mixture [42]. 
Figure 8. Nocapyrones isolated from marine-derived Nocardiopsis. 
 
* Overlapped nomenclatures. 
Figure 9. Natural products existing as mixtures of enantiomers. 
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